Predicting Persistent Post-surgery Pain Predicting Persistent Post-surgery Pain
Might parameters derived from a preoperative cold pain test predict the development of persistent postoperative pain after breast cancer surgery?British Journal of Anaesthesia
Conclusion: Pec II block with ropivacaine delivered under vision reduced analgesic requirement and pain scores significantly.
Conclusion: Dexmedetomidine provided better intraoperative as well as postoperative analgesia than clonidine when administered with ropivacaine in TPVB before breast cancer surgery patients without producing remarkable side effects.
Those who perceived that they received hypnosis had significantly reduced fatigue and anxiety
TUESDAY, Aug. 21, 2018 -- Hypnosis before general anesthesia does not reduce postoperative breast pain among patients undergoing minor breast cancer surgery, according to a study published online Aug. 17 in JAMA Network Open. Jibba Amraoui, M.D.,...
The Erector Spinae Plane (ESP) block, which was first described by Forero in 2016, is currently receiving a lot of attention [1,2]. The ESP block anesthetizes the ventral and dorsal rami of thoracic and lumbar nerves. The technique involves injection a local anesthetic in the plane between the erector spinae muscle and the spinal transverse processes. It has been reported to induce effective analgesia for several surgeries, especially thoracic surgery . The ESP block has also been reported to induce effective analgesia in the perioperative pain management of breast surgeries ; however it was not reported to achieve a...
Conclusions Pecs I is not better than a saline placebo in the presence of multimodal analgesia for breast cancer surgery. However, its role in extended (major) breast surgery may warrant further investigation. Clinical Trial Registration This study was registered at ClinicalTrials.gov, identifier NCT01670448.
This study reviews the effects of propofol on breast cancer cell biology, the immune system, and post-op pain.BMC Anesthesiology
In conclusion, the double-level RLB could delay the time to initial administration of analgesics, but this technique may be insufficient to reduce the analgesic requirement within the 12-hour postoperative period following breast cancer surgery. PMID: 30012909 [PubMed - in process]
Conclusions: Our work clearly demonstrates the inhibitory effects of ropivacaine in breast cancer by disrupting mitochondrial function. Our findings provide a proper understanding of how local anesthetics reduce the risk of tumor recurrence, and thus, support the use of ropivacaine for surgery and to control pain in patients with breast cancer. PMID: 29997943 [PubMed]
Publication date: Available online 1 June 2018Source: Anaesthesia Critical Care &Pain MedicineAuthor(s): C. Riff, A. Diaz, O. Blin, M. Leone, R. Guilhaumou, A. Bourgoin